Inogen Inc (INGN): Byron Myers , Vice President, Marketing of Inogen Inc sold 3,800 shares on Sep 8, 2016. The Insider selling transaction was reported by the company on Sep 12, 2016 to the Securities and Exchange Commission. The shares were sold at $60.04 per share for a total value of $228,263.14 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 19, 2016, Matt Scribner (EVP, Operations) sold 2,320 shares at $56.39 per share price.On Aug 16, 2016, Raymond Huggenberger (CEO) sold 20,747 shares at $57.59 per share price.Also, On Aug 16, 2016, Brenton Taylor (EVP, Engineering) sold 9,271 shares at $56.52 per share price.On Aug 11, 2016, Byron Myers (Vice President, Marketing) sold 13,000 shares at $55.00 per share price.
Inogen Inc: On Monday, Sep 12, 2016 heightened volatility was witnessed in Inogen Inc which led to swings in the share price. The shares opened for trading at $57.61 and hit $59.3 on the upside , eventually ending the session at $58.99, with a gain of 1.71% or 0.99 points. The heightened volatility saw the trading volume jump to 149,159 shares. The 52-week high of the share price is $60.71 and the company has a market cap of $1,185 M . The 52-week low of the share price is at $28.814.
Company has been under the radar of several Street Analysts.Inogen Inc is Downgraded by Stifel to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Aug 5, 2016.Inogen Inc is Resumed by JP Morgan to Overweight. The Rating was issued on Jul 13, 2016.
Inogen Inc. is a medical technology company. The Company is engaged in developing manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company’s Inogen One G2 is effective for nocturnal use.